Less Ads, More Data, More Tools Register for FREE

Pin to quick pickseEnergy Group Regulatory News (EAAS)

Share Price Information for eEnergy Group (EAAS)

Share Price is delayed by 15 minutes
Get Live Data
5.05    0.00 (0.00%)
Bid:
4.80
Ask:
5.30
Spread: 0.50 (10.417%)
Market Cap: £19.55m
EAAS Live PriceLast checked at - London Stock Exchange

Intraday eEnergy Group Share Chart

Operations Update

10 Mar 2009 07:00

RNS Number : 5760O
Alexander Mining PLC
10 March 2009
 



10 March 2009

Alexander Mining plc

("Alexander" or the "Company")

Operations Update

Growing Interest in Proprietary AmmLeach® Technology as Mining Companies Look to Cut Costs

Focus on commercialisation of innovative MetaLeach technologies

Strong interest from mining industry leading to growing test-work revenues 

Ten revenue generating agreements with mining companies signed to date and discussions for many more

Cash at year end £4.9 million, equivalent to 3.7p per share 

Significant reduction in overheads implemented

Expenditure in Argentina cut to a nominal level to maintain Leon project licences

Alexander Mining plc is pleased to report that it is attracting increasing interest in its innovative MetaLeach technologies, which offer potentially substantial mine cost savings. The pressure on mining companies to reduce costs is intense. The MetaLeach technologies have become evermore attractive against the prevailing background of greatly reduced metal prices and falling operating margins.

Alexander is now solely focused on the commercialisation of its proprietary mineral processing technologies. Since the Company's interim results announcement in September 2008, the number of multinational mining groups, as well as intermediate and junior companies eager to investigate the potential of Alexander's technology has expanded. Alexander has already received test-work payments and the pipeline of amenability test-work programmes is increasing steadily.  A major campaign to grow this revenue stream is under way, with the aim of securing future royalties and/or free carried equity interests in attractive base metals projects and/or mines.

AmmLeach®, for which patents are pending, has the potential to revolutionise the extraction processes for high acid consuming copper and zinc oxide deposits. The operating cost differential between AmmLeach® and conventional heap leaching treatment methods for high sulphuric acid consuming ores is a significant order of magnitude in AmmLeach®'s favour.

The AmmLeach® process was developed as a result of Alexander's successful pilot plant demonstration at its Leon copper project in Argentina and subsequent research and development. As well as copper oxides, AmmLeach® has excellent potential for developing a new solvent extraction-electrowinning (SX-EW) process for producing high purity zinc metal or an intermediate product at the mine. 

The zinc process has been trialled successfully on a bench scale and larger scale test-work is imminent. The AmmLeach® process leaches common zinc oxide minerals with high extraction efficiencies and offers a potentially economic processing route for many zinc oxide deposits that are currently uneconomic.

 

The Company is expected to announce its preliminary results for the year ended 31 December 2009 by late April 2009.

For further information please contact:

Martin Rosser

Matt Sutcliffe

Chief Executive Officer

Executive Chairman

Mobile: + 44 (0) 7770 865 341

Mobile: +44 (0) 7887 930 758

Alexander Mining plc

1st Floor

35 Piccadilly

London

W1J 0DW

Tel: +44 (0) 20 7292 1300

Fax: +44 (0) 20 7292 1313

Email: mail@alexandermining.com

Website: www.alexandermining.com

Nominated Advisor and Broker

Alasdair Younie/John Prior

Arbuthnot Securities Limited

Arbuthnot House

20 Ropemaker Street

London

EC2Y 9AR

Tel: +44 (0) 20 7012 2000

Public/Media Relations

Tim Blackstone

Britton Financial PR

62 Britton Street

London

EC1M 5UY

Tel: +44 (0) 20 7242 9786

Mobile: +44 (0) 7957 140 416

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCZGGGFNLDGLZM
Date   Source Headline
1st Jun 20267:00 amRNSPublication of AR, Notice of AGM and Board Update
18th May 20267:00 amRNSDirectorate change
13th May 20267:00 amRNSBoard changes
30th Apr 20267:00 amRNSFinal Results for the Year Ended 31 December 2025
16th Apr 20267:00 amRNSQ1 Trading Update, Revenue Recognition & Outlook
4th Mar 20267:00 amRNS-RContract wins
23rd Feb 20267:00 amRNSLoan Agreement
23rd Jan 20267:00 amRNSTrading Update
22nd Jan 20267:00 amRNSLaunch of new funding solution and first contract
19th Jan 20267:00 amRNSAppointment of Non-Executive Director
15th Dec 20257:00 amRNSFY Trading Update
27th Nov 20257:00 amRNSDirectorate change
17th Nov 20253:20 pmRNSAward of Options
12th Nov 20254:38 pmRNSSolar Agreement, Loan Agreement, Grant of Warrants
29th Oct 202511:39 amRNSHolding(s) in Company
27th Oct 20257:00 amRNS-RLargest EV Charging Project to Date with NHS
23rd Oct 20252:10 pmRNSHolding(s) in Company
20th Oct 20251:28 pmRNSHolding(s) in Company
1st Sep 20257:00 amRNSPreferred supplier for major solar contract
22nd Aug 20253:04 pmRNSHolding(s) in Company
21st Aug 20253:09 pmRNSHolding(s) in Company
19th Aug 202510:50 amRNSHolding(s) in Company
7th Aug 202512:13 pmRNSHolding(s) in Company
31st Jul 20255:17 pmRNSResult of AGM
22nd Jul 20257:00 amRNSUnaudited HY Results - Six Months Ended 30.06.25
3rd Jul 202510:46 amRNSNotice of AGM
30th Jun 20257:00 amRNSNotice of Results
13th Jun 20259:30 amRNSNotice of FY Results and Investor Presentation
3rd Jun 20259:25 amRNSHolding(s) in Company
20th May 202511:10 amRNSHolding(s) in Company
16th May 20257:00 amRNS£100m Partnership with Redaptive
7th Apr 20257:00 amRNS-RFramework win
26th Mar 20257:00 amRNS-RLaunch of SolarLife
24th Mar 20257:00 amRNS-RContracts wins and appointment to a Framework
11th Mar 20257:00 amRNS-RContract Wins
12th Feb 202511:17 amRNSHolding(s) in Company
3rd Feb 20257:00 amRNS-RInvestor Meet Company Presentation
30th Jan 20257:00 amRNSTrading update
19th Dec 20241:45 pmRNSAward of Options and PDMR Transactions
28th Nov 20247:00 amRNS-RLED Conversion Contract in Further Education
15th Oct 202410:45 amRNSHolding(s) in Company
1st Oct 20247:00 amRNSDirector appointment - additional information
30th Sep 20247:00 amRNSResults for the six months ended 30 June 2024
6th Sep 20247:00 amRNSHolding(s) in Company
8th Aug 20247:00 amRNSInvestor Presentations
26th Jul 20247:00 amRNSH1 24 Trading Update
28th Jun 20243:03 pmRNSResult of AGM
13th Jun 20247:00 amRNSNotice of General Meeting
30th Apr 20247:01 amRNSFinal Results for the 18 months ended 31 Dec 2023
22nd Apr 20247:00 amRNSMajor Contract Win with Spire Healthcare

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.